Ticiana A. Leal, MD close
Ticiana A. Leal, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Ticiana A. Leal, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Leal earned her medical degree from the Federal University of Ceara, Brazil, and completed her residency at University of Chicago Hospitals. She completed her fellowship at University of Wisconsin Hospital and Clinics and the University of Illinois. Dr. Leal is board certified in internal medicine, geriatrics, medical oncology and palliative care medicine. 


Medical Oncology

Lung Cancer


UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Hospice and Palliative Medicine
Medical Oncology
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
University of Illinois Medical Center, Chicago, IL
Residency University of Chicago Hospitals, Chicago, IL
Medical School Federal University of Ceara, Fortaleza, Brazil

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Steffen McLouth LE Zhao F Owonikoko TK Feliciano JL Mohindra NA Dahlberg SE Wade JL 3rd Srkalovic G Lash BW Leach JW Leal TA Aggarwal C Cella D Ramalingam SS Wagner LI Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial. Cancer Med . 2020 Oct;9(20):7511-7523
[PubMed ID: 32860331]
Leal TA Argento AC Bhadra K Hogarth DK Grigorieva J Hartfield RM McDonald RC Bonomi PD Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis. Curr Med Res Opin . 2020 Sep;36(9):1497-1505
[PubMed ID: 32615813]
Lema DA Jankowska-Gan E Sethakorn N Burlingham W Leal T Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay. J Immunother Cancer . 2020 Jun;8(1)
[PubMed ID: 32527929]
Horn L Whisenant JG Wakelee H Reckamp KL Qiao H Leal TA Du L Hernandez J Huang V Blumenschein GR Waqar SN Patel SP Nieva J Oxnard GR Sanborn RE Shaffer T Garg K Holzhausen A Harrow K Liang C Lim LP Li M Lovly CM Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer. J Thorac Oncol . 2019 Nov;14(11):1901-1911
[PubMed ID: 31446141]
Nesbit EG Leal TA Kruser TJ What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era? Transl Lung Cancer Res . 2019 Sep;8(Suppl 2):S153-S162
[PubMed ID: 31673520]
Renna CE Dow EN Bergsbaken JJ Leal TA Expansion of pharmacist clinical services to optimize the management of immune checkpoint inhibitor toxicities. J Oncol Pharm Pract . 2019 Jun;25(4):954-960
[PubMed ID: 30975067]
Saunders K Mably MS Shull SS Jones H Leal TA Bergsbaken JJ Implementing value assessment in oncology practice: A single-center experience. J Oncol Pharm Pract . 2019 Jun;25(4):947-953
[PubMed ID: 30482127]
Owonikoko TK Dahlberg SE Sica GL Wagner LI Wade JL 3rd Srkalovic G Lash BW Leach JW Leal TB Aggarwal C Ramalingam SS Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study. J Clin Oncol . 2019 Jan 20;37(3):222-229
[PubMed ID: 30523756]
Horn L Infante JR Reckamp KL Blumenschein GR Leal TA Waqar SN Gitlitz BJ Sanborn RE Whisenant JG Du L Neal JW Gockerman JP Dukart G Harrow K Liang C Gibbons JJ Holzhausen A Lovly CM Wakelee HA Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study. Clin Cancer Res . 2018 Jun 15;24(12):2771-2779
[PubMed ID: 29563138]
Li C Yu J Schehr J Berry SM Leal TA Lang JM Beebe DJ Exclusive Liquid Repellency: An Open Multi-Liquid-Phase Technology for Rare Cell Culture and Single-Cell Processing. ACS Appl Mater Interfaces . 2018 May 23;10(20):17065-17070
[PubMed ID: 29738227]
Leal TA Ramalingam SS Immunotherapy in previously treated non-small cell lung cancer (NSCLC). J Thorac Dis . 2018 Feb;10(Suppl 3):S422-S432
[PubMed ID: 29593888]
Burkard ME Deming DA Parsons BM Kenny PA Schuh MR Leal T Uboha N Lang JM Thompson MA Warren R Bauman J Mably MS Laffin J Paschal CR Lager AM Lee K Matkowskyj KA Buehler DG Rehrauer WM Kolesar J Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor Board. JCO Precis Oncol . 2017;1
[PubMed ID: 32913980]
Schehr JL Schultz ZD Warrick JW Guckenberger DJ Pezzi HM Sperger JM Heninger E Saeed A Leal T Mattox K Traynor AM Campbell TC Berry SM Beebe DJ Lang JM High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1. PLoS One . 2016;11(7):e0159397
[PubMed ID: 27459545]
Halverson JL Martinez-Donate AP Palta M Leal T Lubner S Walsh MC Schaaf Strickland J Smith PD Trentham-Dietz A Health Literacy and Health-Related Quality of Life Among a Population-Based Sample of Cancer Patients. J Health Commun . 2015;20(11):1320-9
[PubMed ID: 26161549]
Leal TB Remick SC Takimoto CH Ramanathan RK Davies A Egorin MJ Hamilton A LoRusso PA Shibata S Lenz HJ Mier J Sarantopoulos J Mani S Wright JJ Ivy SP Neuwirth R von Moltke L Venkatakrishnan K Mulkerin D Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study. Cancer Chemother Pharmacol . 2011 Dec;68(6):1439-47
[PubMed ID: 21479634]
Leal T Chang JE Mehta M Robins HI Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment. Curr Cancer Ther Rev . 2011 Nov;7(4):319-327
[PubMed ID: 23251128]
Loconte NK Williamson A Gayle A Weiss J Leal T Cetnar J Mohammed T Tevaarwerk A Jones N Increasing Disparity in Colorectal Cancer Incidence and Mortality Among African Americans and Whites: A State's Experience. J Gastrointest Oncol . 2011;2(2):85-92
[PubMed ID: 21712962]
Chao BH Lepeak L Leal T Robins HI Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes. Thrombosis . 2011;2011:530183
[PubMed ID: 22084664]
Leal T Tevaarwerk A Love R Stewart J Binkley N Eickhoff J Parrot B Mulkerin D Randomized trial of adjuvant zoledronic acid in postmenopausal women with high-risk breast cancer. Clin Breast Cancer . 2010 Dec 1;10(6):471-6
[PubMed ID: 21147691]
Leal T Robins HI Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report. Cancer Chemother Pharmacol . 2010 Jan;65(2):399-401
[PubMed ID: 19756604]